CVS Health Corp. (CVS)

Sector:Consumer Staples
Super Investor Stats:
Ownership count:5
Ownership rank:63
% of all portfolios:0.118%
Hold Price * :$85.28
History Portfolio Manager Activity Share change % change to portfolio
Q4  2016
Charles Bobrinskoy - Ariel Focus Buy 9,500 1.50
Wallace Weitz - Weitz Value Buy 110,000 1.28
Q3  2016
David Katz - Matrix Advisors Value Add 49.12% 5,600 0.86
Robert Olstein - Olstein Value Add 18.68% 17,000 0.25
Q2  2016
Robert Olstein - Olstein Value Add 42.19% 27,000 0.43
David Katz - Matrix Advisors Value Reduce 2.56% 300 0.05
Q1  2016
David Katz - Matrix Advisors Value Reduce 25.00% 3,900 0.72
Q4  2015
Robert Olstein - Olstein Value Add 42.22% 19,000 0.29
Harry Burn - Sound Shore Sell 100.00% 431,700 2.29
Steven Romick - FPA Crescent Fund Sell 100.00% 507,110 0.50
Q3  2015
David Katz - Matrix Advisors Value Reduce 1.27% 200 0.03
Harry Burn - Sound Shore Reduce 10.08% 48,400 0.26
Robert Olstein - Olstein Value Reduce 21.05% 12,000 0.18
Steven Romick - FPA Crescent Fund Reduce 87.77% 3,639,490 3.59
Charles Bobrinskoy - Ariel Focus Sell 100.00% 27,600 4.76
Q2  2015
Thomas Gayner - Markel Asset Management Add 0.82% 2,000 0.01
Charles Bobrinskoy - Ariel Focus Reduce 4.17% 1,200 0.21
David Katz - Matrix Advisors Value Reduce 7.60% 1,300 0.19
Harry Burn - Sound Shore Reduce 14.05% 78,500 0.36
Q1  2015
Thomas Gayner - Markel Asset Management Add 5.60% 13,000 0.03
David Katz - Matrix Advisors Value Reduce 1.72% 300 0.04
Charles Bobrinskoy - Ariel Focus Reduce 10.00% 3,200 0.51
Robert Olstein - Olstein Value Reduce 24.00% 18,000 0.25
Steven Romick - FPA Crescent Fund Reduce 33.33% 2,073,400 1.95
Q4  2014
Thomas Gayner - Markel Asset Management Add 6.42% 14,000 0.04
Charles Bobrinskoy - Ariel Focus Reduce 4.48% 1,500 0.22
Steven Romick - FPA Crescent Fund Reduce 8.60% 585,000 0.51
David Katz - Matrix Advisors Value Reduce 16.35% 3,400 0.44
Robert Olstein - Olstein Value Reduce 18.48% 17,000 0.24
Harry Burn - Sound Shore Reduce 25.79% 194,100 0.82

* "Hold Price" is the term we use to indicate the price at which our Super Investors are comfortable owning a security. It is the price of the security as of the portfolio date (usually quarter end). It's a reasonable indicator of a stock's undervaluation at that price, otherwise it would have been sold. We only provide this value when a security is owned by at least two Super Investors. In the case of reporting dates being different, we calculate a weighted average price.